Trillium Health Care Products
Acquisition in 2024
Trillium Health Care Products Inc. is a contract manufacturer specializing in prescription and over-the-counter life science products for the pharmaceutical and consumer sectors in North America. Established in 1993 and headquartered in Brockville, Canada, the company provides a diverse range of products, including gastrointestinal remedies, cough, cold and flu medications, antiseptic ointments, nasal sprays, allergy relief solutions, analgesics, sleep aids, and various prescription drugs. Additionally, Trillium manufactures cosmetic products in solid, semi-solid, and liquid forms. The company is recognized for its commitment to integrating sound environmental, health, and safety management practices in its manufacturing processes, catering to the needs of pharmaceutical and consumer companies.
Terrats Medical
Acquisition in 2024
Terrats Medical is a manufacturer specializing in dental implants and prostheses for the medical industry. The company produces a range of products, including dental implants and abutments, and offers related medical devices. In addition to manufacturing, Terrats Medical is involved in the engineering, production, and certification of its products, ensuring that clients have access to dependable abutment production facilities. Through its commitment to quality and innovation, Terrats Medical supports the needs of dental professionals and enhances patient care.
Spear Education
Acquisition in 2022
Spear Education is a provider of education and training services aimed at enhancing the skills of dental professionals. The company offers a range of learning opportunities, including hands-on courses, peer-to-peer regional learning, and comprehensive online educational tools. These programs focus on real-life cases and the latest treatment techniques, fostering an environment of guided learning and interaction among small groups of like-minded peers. By equipping dentists with higher acuity skills and enabling them to generate new revenue streams, Spear Education supports healthcare professionals in improving their knowledge base and achieving a higher return on investment.
Taconic Biosciences
Acquisition in 2022
Taconic Biosciences is a provider of research models for the life sciences, specializing in custom mouse and rat models and related breeding services. The company supplies traditional and genetically engineered cryopreserved and live animals and supports clients in designing, breeding, and preparing models on a fee-for-service basis. Its offerings include transgenic and knockout models, phenotyping, surgical modifications, and related laboratory services to support research across neuroscience, oncology, immunology, metabolism, safety assessment, and vaccine research. Taconic serves pharmaceutical, biotechnology, academic, and contract research organizations and maintains a global network of breeding facilities and laboratories. The company emphasizes ethical animal use and aims to improve human health by supplying relevant models; it traces its history to 1952 and is headquartered in Hudson, New York, with facilities in several countries.
WellSpring Pharmaceutical
Acquisition in 2022
WellSpring Pharmaceutical Corporation, founded in 1999 by Dr. Robert Vukovich, is a privately held company based in Sarasota, Florida, with a manufacturing facility in Ontario, Canada. The company specializes in the manufacture, marketing, and distribution of both prescription and over-the-counter medications. Its product portfolio includes well-known brands such as Emetrol, Micatin, Gelusil, and Glaxal Base Skin Cream and Lotion. WellSpring offers a range of healthcare solutions including heartburn relief, motion sickness remedies, antifungal treatments for athlete's foot and jock itch, infection protection, and skin moisturizers. Additionally, the company provides pharmaceutical contract manufacturing services to clients in North America and Europe, serving consumers, healthcare professionals, and retailers alike.
Probo Medical
Acquisition in 2022
Probo Medical is a supplier of refurbished medical imaging equipment. It offers services including refurbishment, sales, parts, service, and repair for Ultrasound, C-Arms, CT, MRI, PET/CT, X-Ray, and other systems.
Solmetex
Acquisition in 2020
Solmetex, Inc. is a manufacturer based in Northborough, Massachusetts, specializing in amalgam separators for the dental industry in the United States and Canada. Founded in 1994, the company provides a variety of products aimed at water treatment and waste management for dental practices. Its offerings include collection containers, disposal kits suitable for various practice sizes, and approved storage and shipping containers. Notably, the Hg5 Plus system is a specialized solution designed to reduce amalgam waste and dissolved mercury. Solmetex distributes its products through a dealer network across North America, ensuring that dental offices can operate safely and in compliance with environmental regulations.
Vision Healthcare
Acquisition in 2020
Vision Healthcare is a European consumer healthcare company operating a platform that houses a broad portfolio of self-care brands and Over-The-Counter (OTC) products. This includes vitamins, nutritional supplements, cosmetics, personal care items, and OTC medicines. The company employs an omni-channel marketing strategy, with a notable emphasis on online and direct-to-consumer sales channels. Vision Healthcare follows a buy-and-build approach, consolidating the European market and leveraging shared back-end infrastructure for swift organic growth.
GCM Global
Acquisition in 2019
GCM Global is a manufacturer based in Union City, California, specializing in high-precision components and assemblies for the industrial sector. With nearly 40 years of experience, the company offers a comprehensive array of services, including engineering, component manufacturing, supply chain management, precision machining, sheet metal fabrication, and precision assembly. GCM Global is dedicated to providing original equipment manufacturers (OEM) with reliable products, ensuring timely delivery and a wide range of design and manufacturing capabilities. The organization adheres to core values that emphasize professionalism and a commitment to creating exceptional customer experiences.
G&W Laboratories
Acquisition in 2018
G & W Laboratories, Inc. is a pharmaceutical company based in South Plainfield, New Jersey, that develops, manufactures, and markets a wide range of products designed to alleviate human suffering. Established in 1918, the company specializes in generic pharmaceuticals, offering various formulations including analgesics, antifungals, anti-inflammatories, antibiotics, antiemetics, and stimulant laxatives. Its product lineup includes over-the-counter and prescription items, as well as creams, ointments, gels, and suppositories. In addition to its proprietary products, G & W Laboratories provides contract manufacturing services that encompass formulation development, analytical method research and validation, process validation, and commercial batch production. The company distributes its products through retailers, wholesalers, and distributors, and exports to various countries worldwide.
Braeburn
Debt Financing in 2018
Braeburn Inc. is a pharmaceutical company focused on developing and commercializing treatments for serious central nervous system disorders, with a primary emphasis on opioid addiction. Founded in 2012 and headquartered in Plymouth Meeting, Pennsylvania, Braeburn aims to provide innovative solutions for individuals affected by opioid use disorder (OUD). The company's lead product candidate, BRIXADI, is an extended-release injectable formulation of buprenorphine designed for the treatment of moderate to severe OUD. Braeburn is committed to advancing next-generation therapies that offer individualized dosing regimens and delivery options, striving to improve care for patients and address the growing challenges associated with addiction.
United Biosource Corporation
Acquisition in 2017
United Biosource Corporation (UBC) is a prominent provider of pharmaceutical support services that collaborates with life science companies to enhance the safety and accessibility of medicines and medical products. UBC offers a comprehensive range of services designed to connect the development of pharmaceutical products with their delivery to patients. The company focuses on improving patient access to medications and fostering adherence to treatment regimens, ultimately aiming to build brand loyalty among healthcare providers and patients. As part of its commitment to the life sciences sector, UBC plays a critical role in ensuring that innovative therapies reach the market and are effectively utilized by those who need them.
Miraca Life Sciences
Acquisition in 2017
Miraca Life Sciences provides the highest quality anatomic pathology services, primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Miraca Life Sciences continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities and close relationships with clinical partners.
National Spine & Pain Centers
Acquisition in 2017
National Spine & Pain Centers (NSPC) is a prominent operator of interventional pain management clinics headquartered in Frederick, Maryland. With over 120 locations and a network of 750 medical professionals, NSPC serves nearly a million patients annually, focusing on the relief of chronic and acute pain through minimally invasive procedures. The affiliated physicians are highly qualified, often holding double or triple board certifications, and are recognized as leaders in the field of pain management. Additionally, NSPC is committed to advancing pain-related research, with its physicians having authored numerous publications in peer-reviewed medical journals. The organization not only provides administrative support to pain management clinics but also offers management services to physicians in ambulatory surgical centers, ensuring comprehensive care for patients suffering from chronic back and neck pain.
OptiNose is a specialty pharmaceutical company focused on nasal drug delivery technologies and therapies for ear, nose, and throat conditions and related allergies. Its Exhalation Delivery System enables topically acting corticosteroids to reach the upper nasal cavity, supporting the commercial product XHANCE for chronic rhinosinusitis with and without nasal polyps. The company is advancing OPN-300 for Prader-Willi syndrome and autism spectrum disorder. It has licensing agreements for Onzetra Xsail (sumatriptan nasal powder) to treat migraine in adults and collaborates with Inexia Limited to develop orexin receptor targeting medicines. Founded in 2010 and based in Yardley, Pennsylvania, OptiNose aims to broaden nasal delivery with reproducible dosing and reduced systemic exposure.
OptiNose is a specialty pharmaceutical company focused on nasal drug delivery technologies and therapies for ear, nose, and throat conditions and related allergies. Its Exhalation Delivery System enables topically acting corticosteroids to reach the upper nasal cavity, supporting the commercial product XHANCE for chronic rhinosinusitis with and without nasal polyps. The company is advancing OPN-300 for Prader-Willi syndrome and autism spectrum disorder. It has licensing agreements for Onzetra Xsail (sumatriptan nasal powder) to treat migraine in adults and collaborates with Inexia Limited to develop orexin receptor targeting medicines. Founded in 2010 and based in Yardley, Pennsylvania, OptiNose aims to broaden nasal delivery with reproducible dosing and reduced systemic exposure.
OptiNose is a specialty pharmaceutical company focused on nasal drug delivery technologies and therapies for ear, nose, and throat conditions and related allergies. Its Exhalation Delivery System enables topically acting corticosteroids to reach the upper nasal cavity, supporting the commercial product XHANCE for chronic rhinosinusitis with and without nasal polyps. The company is advancing OPN-300 for Prader-Willi syndrome and autism spectrum disorder. It has licensing agreements for Onzetra Xsail (sumatriptan nasal powder) to treat migraine in adults and collaborates with Inexia Limited to develop orexin receptor targeting medicines. Founded in 2010 and based in Yardley, Pennsylvania, OptiNose aims to broaden nasal delivery with reproducible dosing and reduced systemic exposure.
Laredo Energy
Private Equity Round in 2014
Laredo Energy, LLC is a privately held company focused on the acquisition, exploration, and development of natural gas and oil reserves primarily in South Texas and East Central Texas. Founded in 2001 and headquartered in Houston, Texas, with a field office in Laredo, the company has drilled over 200 operated wells in Webb and Zapata counties, while also acquiring interests in several hundred additional wells. Laredo Energy maintains an active drilling program, consistently completing 20 to 30 operated wells each year. The company exports and sells its natural gas to various end markets, both domestically within the United States and internationally.
Rottapharm
Acquisition in 2012
Rottapharm, established in 1961, is a prominent pharmaceutical company rooted in independent research and innovation. Initially focused on pharmaceuticals, the company has expanded its portfolio to include parapharmaceuticals and nutraceuticals. Rottapharm conducts extensive research and development in various therapeutic areas, including gastroenterology, bronchopneumology, psychiatry, rheumatology, urology, gynecology, and oncology. The company also offers a range of personal care products, medical devices, and dermatological solutions. Following its acquisition of the German multinational Madaus Pharma, Rottapharm has solidified its position as one of Italy's leading pharmaceutical firms, with a presence in over 85 countries globally.
Anthony
Acquisition in 2011
Anthony, based in Sylmar, California, is a manufacturer and solutions provider specializing in glass refrigerator and freezer doors, as well as lighting systems and display equipment for commercial refrigeration systems. The company focuses on enhancing merchandising, ensuring food safety, and protecting the environment through its diverse product offerings, which include beer cave doors, Kodiak doors, shelving, viewing windows, sliding doors, and accessories. With over 50 years of commitment to quality, innovation, customer service, continuous improvement, and flexibility, Anthony has established itself as a leading supplier of merchandising components in the refrigeration industry. The company is part of the Refrigeration & Food Equipment segment of Dover Corporation.
DataBank
Acquisition in 2011
DataBank Holdings, Ltd. is a data center and co-location company headquartered in Dallas, Texas, with additional facilities in the Dallas/Fort Worth area, Minneapolis/St. Paul, Eagan, Kansas City, and Atlanta. Founded in 2004, DataBank provides a comprehensive array of services, including co-location solutions that ensure security, power configurations, and cooling. The company also offers managed services such as cloud computing, virtual hosting, network connectivity, and security, along with consulting services that encompass design and implementation, migration, and continuity planning. DataBank emphasizes compliance with various industry standards, including those for payment card security and health data protection. Catering to a diverse clientele across sectors like healthcare, finance, gaming, and hospitality, DataBank is committed to optimizing IT environments and ensuring data availability for enterprises.
OptiNose
Private Equity Round in 2010
OptiNose is a specialty pharmaceutical company focused on nasal drug delivery technologies and therapies for ear, nose, and throat conditions and related allergies. Its Exhalation Delivery System enables topically acting corticosteroids to reach the upper nasal cavity, supporting the commercial product XHANCE for chronic rhinosinusitis with and without nasal polyps. The company is advancing OPN-300 for Prader-Willi syndrome and autism spectrum disorder. It has licensing agreements for Onzetra Xsail (sumatriptan nasal powder) to treat migraine in adults and collaborates with Inexia Limited to develop orexin receptor targeting medicines. Founded in 2010 and based in Yardley, Pennsylvania, OptiNose aims to broaden nasal delivery with reproducible dosing and reduced systemic exposure.
Thompson publishing group
Acquisition in 2006
Thompson Publishing Group is an information service provider specializing in compliance resources, training, online databases, and customized data delivery. They offer a wide range of services including compliance information, training programs, and detailed data in various subject areas such as federal grants, government contracting, FDA regulations, energy policies, and financial services. With a focus on delivering comprehensive and up-to-date information, Thompson Publishing Group serves businesses and professionals seeking reliable resources for staying compliant and informed in their respective industries.
WideOpenWest
Acquisition in 2005
WideOpenWest, operating as WOW!, is a broadband services provider that caters to residential, business, and wholesale customers across the Midwest and Southeast United States. Founded in 1996, the company offers a comprehensive suite of services, including high-speed internet, data, voice, cloud, and cable television. WOW! serves approximately 3.2 million home and business customers, providing them with advanced technologies such as digital cable, HDTV, DVRs, and fiber-based services. The company is committed to delivering quality, affordable services and maintaining a customer-centric culture, as reflected in its five core values. WOW! is privately owned by Avista Capital Partners and is headquartered in Denver, Colorado.